Veloscope

Oral cancer kills one person every hour, 24 hours a day in the United States

  • Oral cancer is the sixth most common cancer in males in the U.S.
  • Unlike several other cancers, the survival rate for oral cancer has remained unchanged for decades
  • The overall 5-year survival rate for oral cancer is 52%, but when discovered early, it increases to over 80%
  • Unfortunately, only 35% of oral cancer cases are diagnosed in the early stages. Why? Because there have been few advances made in screening techniques and there are significant limitations inherent to white light and chemilum-inescence light examination of the oral mucosa
  • Pre-malignant changes actually start below the surface, at the basement membrane. These changes may not be apparent to the naked eye until the disease progresses to the surface

Oral healthcare professionals are the first line of defense in the fight against oral cancer

FLUORESCENCE VISUALIZATION TECHNOLOGY

A new tool for oral mucosal examination VELscope®is a revolutionary hand-helddevice that provides dentists and hygienistswith an easy-to-use adjunctive mucosal examination system for the early detection of abnormal tissue.

The patented VELscope technology platform was developed in collaboration with the British Columbia Cancer Agency and MD Anderson Cancer Center, with funding provided in part by the NIH. It is based on the direct visualization of tissue fluorescence and the changes in fluorescence that occur when abnormalities are present.

The VELscope Handpiece emits a safe blue light into the oral cavity, which excites the tissue from the surface of the epithelium through to the basement membrane and into the stroma beneath, causing it to fluoresce. The clinician is then able toimmediately view the different fluorescence responses to help differentiate between normal and abnormal tissue. In fact, VELscope is the only non-invasive adjunctive device clinically proven to help discover occult oral disease.

Typically, healthy tissue appears as a bright apple-green glow while suspicious regions are identified by a loss of fluorescence, which thus appear dark.